| 000 | 01058 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515005817.0 | ||
| 264 | 0 | _c20060612 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a1744-7658 | ||
| 024 | 7 |
_a10.1517/13543784.14.12.1471 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKonstantinopoulos, Panagiotis A | |
| 245 | 0 | 0 |
_a17-AAG: mechanisms of antitumour activity. _h[electronic resource] |
| 260 |
_bExpert opinion on investigational drugs _cDec 2005 |
||
| 300 |
_a1471-4 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBenzoquinones |
| 650 | 0 | 4 |
_aHSP90 Heat-Shock Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLactams, Macrocyclic |
| 650 | 0 | 4 |
_aRifabutin _xanalogs & derivatives |
| 700 | 1 | _aPapavassiliou, Athanasios G | |
| 773 | 0 |
_tExpert opinion on investigational drugs _gvol. 14 _gno. 12 _gp. 1471-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543784.14.12.1471 _zAvailable from publisher's website |
| 999 |
_c15930673 _d15930673 |
||